Innovating for a healthier future

After decades of restriction, cannabinoids have emerged as a frontier of discovery - interacting with the Endocannabinoid system, an abundant GPCR network; these neuromodulating small molecules can transform human health and wellness.

Merging rational-based drug design with artificial intelligence, FloraWorks' discovery platform Paragon™ will accelerate our understanding of cannabinoids and their physiological responses, leading to actionable nutraceuticals and new drug target identification.